![Abdul Mullick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abdul Mullick
Verkställande Direktör på
KYOWA KIRIN CO., LTD.
Profil
Abdul Mullick is President, CEO, COO & Representative Director at Kyowa Kirin Co., Ltd. since 2026 and Director at Orchard Therapeutics Plc since 2024.
Former roles include President & Chief Executive Officer at Kyowa Kirin International Plc from 2018 to 2023, Director at Mereo BioPharma Group Plc in 2022, Head-Global Strategic Marketing at Vifor Pharma Management AG from 2014 to 2018, Senior Director-European Business Unit at Endocrine Pharmaceuticals Ltd., Senior Director-Global Brand & Diabetes at Novartis Pharma AG, Vice President, GM-Endocrinology & Cardiology at Genzyme Corp.
Education includes a doctorate from the University of Bristol.
Aktiva positioner av Abdul Mullick
| Företag | Position | Start |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Direktör/Styrelseledamot | 2024-01-24 |
| KYOWA KIRIN CO., LTD. | Verkställande Direktör | 2026-03-01 |
Tidigare kända positioner av Abdul Mullick
| Företag | Position | Slut |
|---|---|---|
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Verkställande Direktör | 2023-01-01 |
| MEREO BIOPHARMA GROUP PLC | Direktör/Styrelseledamot | 2022-11-10 |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Företagsledare/Principal | 2018-04-01 |
Endocrine Pharmaceuticals Ltd.
 Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops hormonal drugs | Företagsledare/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | - |
Abdul Mullicks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
15
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocrine Pharmaceuticals Ltd.
Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops hormonal drugs | Commercial Services |
Kyowa Kirin Co., Ltd.
 Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
